PURPOSE: It has been shown that valproic acid (VA) enhances the proliferation and self-renewal of normal hematopoietic stem cells and that breast cancer stem/progenitor cells can be resistant to radiation. From these data, we hypothesized that VA would fail to radiosensitize breast cancer stem/progenitor cells grown to three-dimensional (3D) mammospheres. METHODS AND MATERIALS: We used the MCF7 breast cancer cell line grown under stem cell-promoting culture conditions (3D mammosphere) and standard nonstem cell monolayer culture conditions (two-dimensional) to examine the effect of pretreatment with VA on radiation sensitivity in clonogenic survival assays and on the expression of embryonic stem cell transcription factors. RESULTS: 3D-cultured MCF-7 cells expressed higher levels of Oct4, Nanog, and Sox2. The 3D passage enriched self-renewal and increased radioresistance in the 3D mammosphere formation assays. VA radiosensitized adherent cells but radioprotected 3D cells in single-fraction clonogenic assays. Moreover, fractionated radiation sensitized VA-treated adherent MCF7 cells but did not have a significant effect on VA-treated single cells grown to mammospheres. CONCLUSION: We have concluded that VA might preferentially radiosensitize differentiated cells compared with those expressing stem cell surrogates and that stem cell-promoting culture is a useful tool for in vitro evaluation of novel cancer therapeutic agents and radiosensitizers. Copyright (c) 2010 Elsevier Inc. All rights reserved.
PURPOSE: It has been shown that valproic acid (VA) enhances the proliferation and self-renewal of normal hematopoietic stem cells and that breast cancer stem/progenitor cells can be resistant to radiation. From these data, we hypothesized that VA would fail to radiosensitize breast cancer stem/progenitor cells grown to three-dimensional (3D) mammospheres. METHODS AND MATERIALS: We used the MCF7breast cancer cell line grown under stem cell-promoting culture conditions (3D mammosphere) and standard nonstem cell monolayer culture conditions (two-dimensional) to examine the effect of pretreatment with VA on radiation sensitivity in clonogenic survival assays and on the expression of embryonic stem cell transcription factors. RESULTS: 3D-cultured MCF-7 cells expressed higher levels of Oct4, Nanog, and Sox2. The 3D passage enriched self-renewal and increased radioresistance in the 3D mammosphere formation assays. VA radiosensitized adherent cells but radioprotected 3D cells in single-fraction clonogenic assays. Moreover, fractionated radiation sensitized VA-treated adherent MCF7 cells but did not have a significant effect on VA-treated single cells grown to mammospheres. CONCLUSION: We have concluded that VA might preferentially radiosensitize differentiated cells compared with those expressing stem cell surrogates and that stem cell-promoting culture is a useful tool for in vitro evaluation of novel cancer therapeutic agents and radiosensitizers. Copyright (c) 2010 Elsevier Inc. All rights reserved.
Authors: Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha Journal: Genes Dev Date: 2003-05-15 Impact factor: 11.361
Authors: Kristin M Braun; Catherin Niemann; Uffe B Jensen; John P Sundberg; Violeta Silva-Vargas; Fiona M Watt Journal: Development Date: 2003-09-03 Impact factor: 6.868
Authors: M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel Journal: EMBO J Date: 2001-12-17 Impact factor: 11.598
Authors: Paul Thelen; Stefan Schweyer; Bernhard Hemmerlein; Wolfgang Wuttke; Florian Seseke; Rolf-Hermann Ringert Journal: Int J Oncol Date: 2004-01 Impact factor: 5.650
Authors: Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser Journal: Cell Date: 2009-08-13 Impact factor: 41.582
Authors: Adam R Wolfe; Rachel L Atkinson; Jay P Reddy; Bisrat G Debeb; Richard Larson; Li Li; Hiroko Masuda; Takae Brewer; Bradley J Atkinson; Abeena Brewster; Naoto T Ueno; Wendy A Woodward Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-01 Impact factor: 7.038
Authors: Abdel Nasser Hosein; Yi Chieh Lim; Bryan Day; Brett Stringer; Stephen Rose; Richard Head; Leah Cosgrove; Peter Sminia; Michael Fay; Jennifer H Martin Journal: J Neurooncol Date: 2015-02-04 Impact factor: 4.130
Authors: Krista A Van Nifterik; Jaap Van den Berg; Ben J Slotman; M Vincent M Lafleur; Peter Sminia; Lukas J A Stalpers Journal: J Neurooncol Date: 2011-10-26 Impact factor: 4.130
Authors: Susanna H Wegner; Julie Juyoung Park; Tomomi Workman; Sanne A B Hermsen; Jim Wallace; Ian B Stanaway; Hee Yeon Kim; William C Griffith; Sungwoo Hong; Elaine M Faustman Journal: Reprod Toxicol Date: 2019-11-16 Impact factor: 3.143
Authors: Hee Yeon Kim; Susanna H Wegner; Kirk P Van Ness; Julie Juyoung Park; Sara E Pacheco; Tomomi Workman; Sungwoo Hong; William Griffith; Elaine M Faustman Journal: Reprod Toxicol Date: 2016-08-11 Impact factor: 3.143
Authors: Bisrat G Debeb; Xiaomei Zhang; Savitri Krishnamurthy; Hui Gao; Evan Cohen; Li Li; Angel A Rodriguez; Melissa D Landis; Anthony Lucci; Naoto T Ueno; Fredika Robertson; Wei Xu; Lara Lacerda; Thomas A Buchholz; Massimo Cristofanilli; James M Reuben; Michael T Lewis; Wendy A Woodward Journal: Mol Cancer Date: 2010-07-08 Impact factor: 27.401
Authors: Bisrat G Debeb; Lara Lacerda; Wei Xu; Richard Larson; Travis Solley; Rachel Atkinson; Erik P Sulman; Naoto T Ueno; Savitri Krishnamurthy; James M Reuben; Thomas A Buchholz; Wendy A Woodward Journal: Stem Cells Date: 2012-11 Impact factor: 6.277
Authors: Lara Lacerda; Jay P Reddy; Diane Liu; Richard Larson; Li Li; Hiroko Masuda; Takae Brewer; Bisrat G Debeb; Wei Xu; Gabriel N Hortobágyi; Thomas A Buchholz; Naoto T Ueno; Wendy A Woodward Journal: Stem Cells Transl Med Date: 2014-05-15 Impact factor: 6.940